Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-18

Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Anotinib hydrochloride with Epirubicin vs placebo with Epirubicin for first-line treatment of advanced soft tissue sarcoma; current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anotinib hydrochloride (Anotinib hydrochloride)
  • Epirubicin hydrochloride (epirubicin hydrochloride)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: UNKNOWN